Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000950170-24-139356·AIM ImmunoTech Inc.
Schedule 13D ownership disclosure
AIM IMMUNOTECH INC
Common Stock, par value $0.001 per share · CUSIP: 00901B105
Event date: 2024-12-19
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Todd DeutschReported CIK 0001709836
Shares: 1,716,100 · Class: 2.7%
- Ted D. KellnerReported CIK 0001187524
Shares: 1,493,000 · Class: 2.3%
- Paul W. Sweeney
Shares: 2,000 · Class: 0%
- Wayne SpringateReported CIK 0001465652
Shares: 4,660 · Class: 0.01%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-24-139356
- Form type
- SCHEDULE 13D/A
- Filer
- AIM ImmunoTech Inc.
- CIK
- CIK 946644
- Filed
- Dec 23, 2024
- Reporting period
- Dec 19, 2024
- Description
- Schedule 13D beneficial ownership